KAP DAP Dose Report: How to Read and Explain Your Fluoroscopy Metrics

Introduction

Every fluoroscopy system generates a dose report at the conclusion of each procedure. For most interventional teams, this report is filed, archived, and forgotten—an administrative artifact rather than a clinical tool. This is a profound waste. The dose report contains the quantitative evidence of procedural safety: air kerma, kerma-area product (KAP), fluoroscopy time, cine acquisition details, and—on modern systems—an estimate of peak skin dose (PSD). Operators who cannot read these metrics cannot audit their own performance, cannot benchmark against colleagues, and cannot identify the specific behaviors driving high-dose outliers.

The knowledge gap is real and consequential. A 2021 international survey of 708 interventional pain physicians revealed that nearly half were either unaware of or confused about occupational dose limits, and significant proportions lacked confidence in interpreting dose metrics or responding to radiation emergencies.^[1] This deficit is not limited to pain medicine; it pervades interventional cardiology, radiology, and surgery. When technologists cannot interpret the numbers on the dose report, they cannot serve as the frontline quality assurance officers that modern radiation safety demands.

This article provides the comprehensive framework for understanding, interpreting, and acting upon fluoroscopy dose reports. It explains the physics and clinical significance of each metric, introduces derived indices that reveal operator behavior, and establishes the alert thresholds that should trigger immediate clinical action. The goal is to empower every member of the interventional team to independently audit performance and understand dose reports as living documents of procedural safety.

The five essential dose quantities

Before interpreting a dose report, the interventional team must speak a common quantitative language. Five dose quantities appear on every modern fluoroscopy report, each measuring a different aspect of radiation delivery:

1. Air kerma (K_a,r): The kinetic energy released per unit mass in air at the interventional reference point, measured in gray (Gy). This estimates the entrance skin dose.
2. Kerma-area product (KAP): Also called dose-area product (DAP), measured in Gy·cm². This reflects total energy delivered to the patient based on beam area.
3. Fluoroscopy time: The cumulative duration of live fluoroscopy, measured in minutes.
4. Cine time / number of runs: The duration and count of cine acquisitions, which deliver approximately 10–20 times the dose rate of fluoroscopy.
5. Peak skin dose (PSD): The maximum dose delivered to any point on the patient’s skin, estimated by the system or calculated post-procedure.

Understanding the distinction between these quantities is foundational. Air kerma tells you about intensity at a single point. KAP tells you about total energy delivered across the entire field. Fluoroscopy and cine times reveal operator behavior. PSD tells you whether deterministic injury thresholds have been approached.^[3]

Air kerma: entrance skin intensity

Air kerma (K_a,r) is the kinetic energy released per unit mass of air by indirectly ionizing radiation at the interventional reference point. In practical terms, it estimates the radiation intensity at the patient’s skin entrance surface. The unit is the gray (Gy), where 1 Gy = 1 joule per kilogram.^[4]

Modern angiographic systems measure air kerma in real time and display cumulative values throughout the procedure. This metric is the primary indicator of deterministic risk to the patient. The FDA has established that skin doses exceeding 2 Gy may cause transient erythema, while doses above 5 Gy carry a significant risk of clinically important skin injury requiring follow-up.^[5]

For operators, air kerma is also a behavioral metric. A high air kerma relative to procedural complexity suggests excessive use of high-dose modes, prolonged fluoroscopy, or steep angulations that increase tissue attenuation and trigger automatic exposure control to raise dose rates. Tracking air kerma per case, per operator, and per procedure type is the first step in identifying outliers.

KAP and DAP: total energy delivered

The kerma-area product (KAP), also known as the dose-area product (DAP), is defined as the product of air kerma at the interventional reference point and the cross-sectional area of the x-ray beam:

KAP = K_a,r × A

where A is the beam area in cm². The unit is Gy·cm². KAP is the most useful single metric for quality assurance because it integrates both dose rate and field size into a single value that correlates with total energy delivered to the patient and, by extension, total scatter generated toward staff.^[6]

Unlike air kerma, KAP is relatively insensitive to changes in source-to-skin distance. If the patient moves closer to the source, air kerma increases (inverse square law), but beam area at the patient surface decreases proportionally, leaving KAP approximately constant. This makes KAP a robust metric for comparing procedures performed with different geometries or on patients of different sizes.

The AAPM Medical Physics Practice Guideline 12.a recommends that facilities calculate KAP for each fluoroscopic examination and compare values against diagnostic reference levels.^[7] For interventional procedures, typical KAP values range from 10–50 Gy·cm² for diagnostic angiography to 100–300 Gy·cm² for complex structural interventions. Values exceeding 500 Gy·cm² should trigger mandatory review.

Peak skin dose: the deterministic threshold

Peak skin dose (PSD) is the maximum radiation dose delivered to any point on the patient’s skin during a procedure. Unlike air kerma, which is measured at a reference point, PSD accounts for beam overlap from multiple projections and prolonged irradiation of the same skin area. It is the metric that determines whether deterministic skin injury thresholds have been crossed.^[8]

Modern angiographic systems estimate PSD using software algorithms that model beam geometry, projection angles, and irradiation time. While these estimates are not as accurate as direct measurement with radiochromic film, they provide a clinically useful approximation for post-procedure risk stratification.^[9]

Skin dose thresholds and clinical actions

• < 2 Gy: No action required. Standard post-procedure care.
• 2–5 Gy: Document in medical record. Inform patient to monitor for delayed erythema (latency 2–5 weeks). Schedule follow-up at 3 weeks.
• 5–10 Gy: Mandatory case review. Formal patient notification. Dermatology consultation. Photograph baseline skin. Follow-up at 2, 4, and 8 weeks.
• > 10 Gy: Permanent injury risk. Immediate multidisciplinary review. Mandatory reporting to radiation safety officer. Structured long-term follow-up.

The FDA explicitly recommends that facilities establish procedures to identify patients who receive cumulative air kerma exceeding 5 Gy and to provide follow-up care for potential radiation-induced skin injuries.^[5]

Derived metrics: what your dose report really tells you

Raw dose metrics tell only part of the story. By calculating derived indices, quality assurance teams can identify specific behavioral and technical drivers of high dose. The following derived metrics should be calculated for every procedure and reviewed at monthly quality meetings:^[7]

KAP ÷ K_a,r = Average field area

This ratio reveals collimation practice. A high value indicates large field sizes; a low value indicates tight collimation. For coronary angiography, typical values are 20–40 cm². Values above 60 cm² suggest poor collimation habit.

K_a,r ÷ Fluoroscopy time = Average dose rate

This ratio reveals the intensity of fluoroscopy use. High values suggest excessive high-dose modes, steep angulations, or prolonged cine acquisition misclassified as fluoroscopy. For diagnostic coronary work, typical values are 20–50 mGy/min.

Cine time ÷ Total procedure time = Cine dependency

This ratio reveals reliance on cine acquisition for documentation. Values above 10% suggest cine overuse. Stored fluoroscopy loops and last-image hold frames should replace cine for most documentation needs.

KAP per procedure type = Benchmarking index

Comparing KAP across operators for the same procedure type reveals outliers. Differences of more than 50% between operators performing the same procedure warrant case review and technique comparison.

Clinical alert thresholds and mandatory actions

Dose reports are only useful if they trigger action. Every interventional facility should establish institutional alert thresholds with defined clinical responses. The following framework is based on FDA recommendations, ICRP guidance, and published diagnostic reference levels:^[2,5,10]

Yellow alert (cumulative air kerma 1.5–2.0 Gy)

• Verbal notification to operator.
• Reassess projection angles, pulse rate, and cine usage.
• Consider staging the procedure if additional complex work remains.

Orange alert (cumulative air kerma 2.0–5.0 Gy)

• Mandatory timeout to reassess technique.
• Document cumulative dose and projections in procedure note.
• Inform patient of potential for delayed skin changes.
• Schedule follow-up at 3 weeks.

Red alert (cumulative air kerma > 5.0 Gy)

• Mandatory case review within 48 hours.
• Formal patient notification and education.
• Dermatology consultation and baseline photography.
• Root-cause analysis with operator feedback.
• Report to radiation safety officer and institutional quality committee.

These thresholds should be programmed into the angiographic system as audible and visible alerts. Real-time feedback has been shown to reduce operator dose by 15–25% through behavioral modification alone.^[11] When operators see cumulative dose approaching alert thresholds, they consciously reduce fluoroscopy time, limit cine acquisition, and revert to lower-dose projections.

Further reading

Conclusion

The dose report is not an administrative afterthought—it is the quantitative record of procedural safety. Operators who understand air kerma, KAP, peak skin dose, and derived metrics can audit their own performance, identify outliers, and optimize technique in real time. Technologists who can interpret these numbers serve as frontline quality assurance officers, catching protocol drift before it becomes habit.

The five essential quantities—air kerma, KAP, fluoroscopy time, cine details, and peak skin dose—tell a complete story when analyzed together. High air kerma with normal KAP suggests tight collimation but high dose rate. High KAP with normal air kerma suggests wide fields with reasonable dose rate. High cine time relative to fluoroscopy suggests documentation overuse. Only by examining all metrics can teams diagnose the specific driver of excessive dose.

Institutional alert thresholds transform passive documentation into active safety infrastructure. Yellow, orange, and red alerts with defined clinical responses ensure that high-dose cases receive the attention they deserve. Real-time displays, audible alarms, and mandatory follow-up protocols close the loop between measurement and action. SATMED Health’s cloud-based dose monitoring platform extends these capabilities to remote and resource-limited clinics, ensuring that every interventional team—regardless of geography—has access to the metrics, alerts, and benchmarks required for safe practice.

The dose report is where ALARA meets accountability. Learn to read it. Learn to explain it. And most importantly, learn to act on it.

References

1. Provenzano, D. A., Florentino, S. A., Kilgore, J. S., Somerson, J. S., Bhakta, A., & Liu, J. (2021). Radiation safety and knowledge: An international survey of 708 interventional pain physicians. Regional Anesthesia & Pain Medicine, 46(6), 469–476. https://doi.org/10.1136/rapm-2020-102002
2. ICRP. (2018). Occupational radiological protection in interventional procedures (ICRP Publication 139). Annals of the ICRP, 47(2). https://doi.org/10.1177/0146645317750356
3. Miller, D. L. (2020). Review of air kerma-area product, effective dose and dose conversion coefficients for non-cardiac interventional fluoroscopy procedures. Medical Physics, 47(3), 975–982. https://doi.org/10.1002/mp.13975
4. International Commission on Radiological Protection. (2021). Use of dose quantities in radiological protection (ICRP Publication 147). Annals of the ICRP, 50(1). https://doi.org/10.1177/01466453211001435
5. FDA. (2018). Avoidance of serious x-ray-induced skin injuries to patients during fluoroscopically-guided procedures. https://www.fda.gov/media/74894/download
6. ScienceDirect. (2025). Dose area product. https://www.sciencedirect.com/topics/medicine-and-dentistry/dose-area-product
7. AAPM. (2019). AAPM Medical Physics Practice Guideline 12.a: Fluoroscopy dose management. Journal of Applied Clinical Medical Physics, 20(1), 7–28. https://doi.org/10.1002/acm2.12504
8. Jaschke, W., Schmuth, M., Trianni, A., & Bartal, G. (2017). Radiation-induced skin injuries to patients from interventional fluoroscopy: Dosimetric and clinical approach. European Radiology, 27(6), 2358–2366. https://doi.org/10.1007/s00330-016-4600-9
9. Jones, A. K., Wunderle, K. A., Fruscello, T., Simanowith, M., Cline, B., Dharmadhikari, S., & Miller, D. L. (2023). Patient radiation doses in interventional radiology procedures. Journal of Vascular and Interventional Radiology, 34(4), 556–562. https://doi.org/10.1016/j.jvir.2022.12.013
10. ACR–AAPM–SPR. (2021). Practice parameter for diagnostic reference levels and achievable doses in medical x-ray imaging. American College of Radiology. https://www.acr.org/-/media/ACR/Files/Practice-Parameters/DiagnosticRefLevels.pdf
11. Boon, S. N., Jeukens, C. R. L. P. N., & Karmann-Sailer, A. (2016). Real-time patient and staff radiation dose monitoring in IR practice. CardioVascular and Interventional Radiology, 40(3), 422–429. https://doi.org/10.1007/s00270-016-1526-8
12. Borrego, D., Kitahara, C. M., Balter, S., & Yoder, C. (2020). Occupational doses to medical staff performing or assisting with fluoroscopically guided interventional procedures. Radiology, 294(2), 353–359. https://doi.org/10.1148/radiol.2020191234
13. Stahl, C. M., Meisinger, Q. C., Andre, M. P., Kinney, T. B., & Newton, I. G. (2016). Radiation risk to the fluoroscopy operator and staff. American Journal of Roentgenology, 207(4), 737–744. https://doi.org/10.2214/AJR.15.15057
14. Dauer, L. T., Miller, D. L., Schueler, B., Silberzweig, J., Balter, S., Bartal, G., & Cardella, J. F. (2015). Occupational radiation protection of pregnant or potentially pregnant workers in IR. Journal of Vascular and Interventional Radiology, 26(2), 171–181. https://doi.org/10.1016/j.jvir.2014.10.021
15. Milder, C. M., Borrego, D., Preston, D. L., Villoing, D., Kwon, T. E., Miller, D. L., & Little, M. P. (2024). Occupational radiation dose trends in US radiologic technologists assisting with fluoroscopically guided interventional procedures, 1980–2020. Journal of Vascular and Interventional Radiology, 35(7), 1057–1065. https://doi.org/10.1016/j.jvir.2024.03.018
16. European Commission. (2026). Commission Recommendation on diagnostic reference levels (Euratom/2026/403). https://energy.ec.europa.eu/news/medical-use-ionising-radiation-commission-recommendation-diagnostic-reference-levels-2026-02-23_en
17. Kim, J. S., et al. (2026). First national diagnostic reference levels established for cardiovascular interventional procedures. Applied Sciences, 16(9), 4466. https://doi.org/10.3390/app16094466
18. Schueler, B. A., & Fetterly, K. A. (2021). Eye protection in interventional procedures. British Journal of Radiology, 94(1126), 20210436. https://doi.org/10.1259/bjr.20210436
19. Ko, S., Kang, S., Ha, M., Kim, J., Jun, J. K., Kong, K. A., & Lee, W. J. (2018). Health effects from occupational radiation exposure among fluoroscopy-guided interventional medical workers: A systematic review. Journal of Vascular and Interventional Radiology, 29(3), 353–366. https://doi.org/10.1016/j.jvir.2017.11.011
20. Cornelis, F. H., Razakamanantsoa, L., Ben, A. M., Lehrer, R., Haffaf, I., El-Mouhadi, S., & Sapoval, M. (2021). Ergonomics in interventional radiology: Awareness is mandatory. Medicina, 57(5), 500. https://doi.org/10.3390/medicina57050500
21. Baudin, C., Vacquier, B., Thin, G., Chenene, L., Guersen, J., Partarrieu, I., & Grellier, N. (2023). Occupational exposure to ionizing radiation in medical staff: Trends during the 2009–2019 period in a multicentric study. European Radiology, 33(8), 5675–5684. https://doi.org/10.1007/s00330-023-09347-8
22. Wunderle, K. A., Chung, M. K., Rayadurgam, S., Miller, M. A., Obuchowski, N. A., & Lindsay, B. D. (2019). Occupational and patient radiation doses in a modern cardiac electrophysiology laboratory. Journal of Interventional Cardiac Electrophysiology, 56(2), 183–190. https://doi.org/10.1007/s10840-019-00558-3
23. EVTODAY. (2024). Radiation safety: A field guide to terminology. https://evtoday.com/articles/2024-june/radiation-safety-a-field-guide-to-terminology
24. PMC. (2025). Radiation safety: knowledge, attitudes, practices and training needs. https://pmc.ncbi.nlm.nih.gov/articles/PMC12010179/
25. PMC. (2025). Calibration and evaluation of a dose area product (DAP) meter. https://pmc.ncbi.nlm.nih.gov/articles/PMC12005669/

SATMED Health Clinical Calculators

Medically Reviewed by Prof. Dr. Damien O’Neil, MD, PhD

Last updated: August 5, 2026 | Reviewed for clinical accuracy and adherence to the latest guidelines of the American College of Radiology (ACR), Radiological Society of North America (RSNA), International Commission on Radiological Protection (ICRP), Society of Interventional Radiology (SIR), and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).

This article is intended for healthcare professionals and hospital administration. It does not constitute individual clinical advice. Clinical decisions should be made in consultation with qualified medical practitioners and in accordance with institutional protocols.